Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder

被引:30
作者
Arab, Juan P. [1 ,2 ,3 ,7 ,8 ]
Addolorato, Giovanni [4 ]
Mathurin, Philippe [5 ]
Thursz, Mark R. [6 ]
机构
[1] Western Univ, Schulich Sch Med, Dept Med, Div Gastroenterol, London, ON, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Pontificia Univ Catolica Chile, Escuela Med, Dept Gastroenterol, Santiago, Chile
[4] Univ Cattolica Sacro Cuore, Dept Med & Surg Sci, Internal Med & Hepatol Unit, Rome, Italy
[5] Ctr Hosp Univ Lille, Hop Huriez, Serv Malad Appareil Digest, Lille, France
[6] Imperial Coll, Div Digest Dis, London, England
[7] Western Univ, Univ Hosp, Div Gastroenterol & Hepatol, 339 Windermere Rd,Room A10-224, London, ON N6A 5A5, Canada
[8] Univ Hosp, London Hlth Sci Ctr, 339 Windermere Rd,Room A10-224, London, ON N6A 5A5, Canada
基金
英国医学研究理事会;
关键词
Alcohol; Cirrhosis; Alcohol-Associated Hepatitis; Alcohol Use Disorder; Fatty Liver Disease; PRACTICE GUIDELINE; N-ACETYLCYSTEINE; CLINICAL-TRIALS; LILLE MODEL; HEPATITIS; TRANSPLANTATION; MORTALITY; PREDICTS; AUDIT; CORTICOSTEROIDS;
D O I
10.1016/j.cgh.2023.02.017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Alcohol-associated liver disease (ALD) is the most common cause of cirrhosis and liver-related mortality in many re-gions worldwide. Around 75% of patients with cirrhosis are unaware of their disease until they are referred to the emergency department. An innovative, noninvasive screening approach is required for an earlier diagnosis of liver fibrosis. In patients with ALD the physician is inevi-tably dealing with 2 major disorders: the liver disease it-self and the alcohol use disorder (AUD). Focus only on the liver disease will inevitably lead to failure because tran-sient improvements in liver function are rapidly over-turned if the patient returns to alcohol consumption. For this reason, integrated models of care provided by hep-atologists and addiction specialists are an effective approach, which are, however, not widely available. There are multiple pharmacologic and non-pharmacologic ther-apies for AUD. Progress has recently been made in the management of patients with severe AH who have improved survival through better understanding of the concept of response to medical treatment, improved sur-vival prediction, and the advent of early liver trans-plantation. The emerging concept is that listing for transplantation a patient with severe ALD could lead to adjusting the duration of abstinence according to the severity and evolution of liver dysfunction and the pa-tient's addictive profile.
引用
收藏
页码:2124 / 2134
页数:11
相关论文
共 50 条
[31]   Alcohol-associated liver disease: Natural history, management and novel targeted therapies [J].
Alvarado-Tapias, Edilmar ;
Pose, Elisa ;
Gratacos-Gines, Jordi ;
Clemente-Sanchez, Ana ;
Lopez-Pelayo, Hugo ;
Bataller, Ramon .
CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 :S112-S133
[32]   Safety and Tolerability of Injectable Extended-Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease [J].
Diaz, Luis Antonio ;
Collier, Summer ;
Yin, Jeffrey ;
Loomba, Rohit .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
[33]   Gut Microbiome and Alcohol-associated Liver Disease [J].
Philips, Cyriac A. ;
Schnabl, Bernd ;
Bajaj, Jasmohan S. .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (05) :1349-1359
[34]   Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder [J].
Vannier, Augustin G. L. ;
Shay, Jessica E. S. ;
Fomin, Vladislav ;
Patel, Suraj J. ;
Schaefer, Esperance ;
Goodman, Russell P. ;
Luther, Jay .
JAMA NETWORK OPEN, 2022, 5 (05) :E2213014
[35]   New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease [J].
Diaz, Luis Antonio ;
Winder, Gerald Scott ;
Leggio, Lorenzo ;
Bajaj, Jasmohan S. ;
Bataller, Ramon ;
Arab, Juan Pablo .
HEPATOLOGY, 2025, 82 (01) :254-271
[36]   Liver transplantation for Alcohol-associated liver disease [J].
Simonetto, Douglas A. ;
Winder, G. Scott ;
Connor, Ashton A. ;
Terrault, Norah A. .
HEPATOLOGY, 2024, 80 (06) :1441-1461
[37]   Management of alcohol withdrawal syndrome in patients with alcohol-associated liver disease [J].
Ratner, Jessica A. ;
Blaney, Hanna ;
Rastegar, Darius A. .
HEPATOLOGY COMMUNICATIONS, 2024, 8 (02)
[38]   Challenges in the management of alcohol-associated liver disease in Latin America [J].
Idalsoaga, Francisco ;
Diaz, Luis Antonio ;
Ayares, Gustavo ;
Arrese, Marco ;
Arab, Juan Pablo .
ANNALS OF HEPATOLOGY, 2025, 30 (01)
[39]   Extrahepatic Health Effects of Alcohol Use and Alcohol-associated Liver Disease [J].
Abbas, Daniyal ;
Ciricillo, Jacob A. ;
Elom, Hilary A. ;
Moon, Andrew M. .
CLINICAL THERAPEUTICS, 2023, 45 (12) :1201-1211
[40]   Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action [J].
Lamia Y. Haque ;
Paola Zuluaga ;
Robert Muga ;
Daniel Fuster .
Addiction Science & Clinical Practice, 19